Literature DB >> 678422

A soft-agar procedure measuring growth of human colonic carcinomas.

P M Kimball, M G Brattain, A M Pitts.   

Abstract

Cell suspensions from 5 human colonic carcinomas were fractionated by velocity sedimentation and plated in soft agar. Cluster formation was restricted to the purest fraction of epithelial cells, as had been determined by immuno- and histochemical criteria. Plating efficiencies for the 5 specimens were 1.0-4.5%. The effects of varying the incubation period and inoculum size upon growth were studied using unseparated cell suspensions from 6 specimens. Clusters were apparent after 3 weeks in culture, and maximum cluster formation was typically seen by 5 weeks. Cluster formation appeared concentration-dependent, and individual specimens varied with respect to the inoculum most conducive to growth. The maximum plating efficiencies for unseparated cells were unseparated cells were 0.4-1.7%.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 678422      PMCID: PMC2009639          DOI: 10.1038/bjc.1978.147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  A rapid method for establishing short-term primary cultures of human tumor cells from fresh tumor biopsies.

Authors:  G M Mavligit; P B Barsales; J U Gutterman; B Mackay; E M Hersh
Journal:  Proc Soc Exp Biol Med       Date:  1975-12

2.  Cell fractionation of large bowel cancer.

Authors:  M G Brattain; T P Pretlow; T G Pretlow
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

3.  Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas.

Authors:  C J Marshall; L M Franks; A W Carbonell
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

4.  beta-Hexosaminidase isozymes in human colonic carcinoma.

Authors:  M G Brattain; P M Kimball; T G Pretiow
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

5.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

6.  The use of the Robinson in vitro agar culture assay in adult acute leukemia.

Authors:  G Spitzer; K A Dicke; E A Gehan; T Smith; K B McCredie
Journal:  Nouv Rev Fr Hematol Blood Cells       Date:  1976

7.  Growth kinetics of human large bowel cancer growing in immune-deprived mice and some chemotherapeutic observations.

Authors:  L F Lamerton; G G Steel
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

8.  Partial purification of human colonic carcinoma cells by sedimentation.

Authors:  M G Brattain; P M Kimball; T G Pretlow; A M Pitts
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

9.  Ultrastructural analysis of hematopoietic colonies derived from human peripheral blood. A newly developed method.

Authors:  D Zucker-Franklin; G Grusky
Journal:  J Cell Biol       Date:  1974-12       Impact factor: 10.539

10.  A colony-forming assay for human tumour xenografts using agar in diffusion chambers.

Authors:  I E Smith; V D Courtenay; M Y Gordon
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  4 in total

Review 1.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

2.  Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.

Authors:  D B Herrmann; H A Neumann
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

3.  Clonogenic growth and hormone sensitivity of benign and malignant breast tissues.

Authors:  V Hug; R Rashid; D Johnston; G Hortobagyi
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

4.  Antigenic heterogeneity and individuality in adenocarcinomas of the rectum and their secondaries.

Authors:  P Enblad; B Glimelius; C Busch; J Pontén; L Påhlman
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.